 | • レポートコード：GIR201100052 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、23価肺炎球菌多糖ワクチンの世界市場を調査対象にし、23価肺炎球菌多糖ワクチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（単回バイアル、プレフィルドシリンジ）、用途別分析（子供用（2-10）、人用（10-64）、高齢者用（≥65））、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：MSD、Sanofipasteur、CDIBP ・メーカー別販売量、売上、市場シェア ・23価肺炎球菌多糖ワクチンの地域別市場分析 ・23価肺炎球菌多糖ワクチンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・23価肺炎球菌多糖ワクチンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・23価肺炎球菌多糖ワクチンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・23価肺炎球菌多糖ワクチンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・23価肺炎球菌多糖ワクチンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・23価肺炎球菌多糖ワクチンの種類別市場規模2015-2020：単回バイアル、プレフィルドシリンジ ・23価肺炎球菌多糖ワクチンの用途別市場規模2015-2020：子供用（2-10）、人用（10-64）、高齢者用（≥65） ・23価肺炎球菌多糖ワクチンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global 23-Valent Pneumococcal Polysaccharide Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 13.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 3549.3 million by 2025, from USD 2117.7 million in 2019.
Market segmentation
23-Valent Pneumococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, 23-Valent Pneumococcal Polysaccharide Vaccine market has been segmented into
Single Dose Vial
Pre-filled Syringe
By Application, 23-Valent Pneumococcal Polysaccharide Vaccine has been segmented into:
For Children (2-10)
For Person (10-64)
For The Old (≥65)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global 23-Valent Pneumococcal Polysaccharide Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level 23-Valent Pneumococcal Polysaccharide Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global 23-Valent Pneumococcal Polysaccharide Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the 23-Valent Pneumococcal Polysaccharide Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Analysis
23-Valent Pneumococcal Polysaccharide Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, 23-Valent Pneumococcal Polysaccharide Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the 23-Valent Pneumococcal Polysaccharide Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in 23-Valent Pneumococcal Polysaccharide Vaccine are:
MSD
Sanofipasteur
CDIBP
Among other players domestic and global, 23-Valent Pneumococcal Polysaccharide Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 23-Valent Pneumococcal Polysaccharide Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of 23-Valent Pneumococcal Polysaccharide Vaccine in 2018 and 2019.
Chapter 3, the 23-Valent Pneumococcal Polysaccharide Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 23-Valent Pneumococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, 23-Valent Pneumococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe 23-Valent Pneumococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market Analysis by Application
1.3.1 Overview: Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (≥65)
1.4 Overview of Global 23-Valent Pneumococcal Polysaccharide Vaccine Market
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 MSD
2.1.1 MSD Details
2.1.2 MSD Major Business
2.1.3 MSD SWOT Analysis
2.1.4 MSD Product and Services
2.1.5 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofipasteur
2.2.1 Sanofipasteur Details
2.2.2 Sanofipasteur Major Business
2.2.3 Sanofipasteur SWOT Analysis
2.2.4 Sanofipasteur Product and Services
2.2.5 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CDIBP
2.3.1 CDIBP Details
2.3.2 CDIBP Major Business
2.3.3 CDIBP SWOT Analysis
2.3.4 CDIBP Product and Services
2.3.5 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
4.5 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
6.3 UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
6.4 France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.5 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2015-2020)
11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Application
11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
11.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
12.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
12.2.4 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025)
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2021-2025)
12.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. MSD Basic Information, Manufacturing Base and Competitors
Table 9. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Major Business
Table 10. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Total Revenue (USD Million) (2018-2019)
Table 11. MSD SWOT Analysis
Table 12. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 13. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table 15. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Major Business
Table 16. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Total Revenue (USD Million) (2018-2019)
Table 17. Sanofipasteur SWOT Analysis
Table 18. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 19. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. CDIBP Basic Information, Manufacturing Base and Competitors
Table 21. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Major Business
Table 22. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Total Revenue (USD Million) (2018-2019)
Table 23. CDIBP SWOT Analysis
Table 24. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 25. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2018-2019) (K Dose)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Regions (2015-2020) (K Dose)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2015-2020)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 31. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2015-2020) (K Dose)
Table 32. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Table 33. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 34. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Table 35. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2015-2020) (K Dose)
Table 36. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Table 37. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 38. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Regions (2015-2020) (K Dose)
Table 39. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2015-2020)
Table 40. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 41. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2015-2020) (K Dose)
Table 42. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Table 43. South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 44. South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Table 45. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries (2015-2020) (K Dose)
Table 46. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Table 47. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 48. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Table 49. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2015-2020) (K Dose)
Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2015-2020)
Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2015-2020) (USD Million)
Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2015-2020)
Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2015-2020) (K Dose)
Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2015-2020)
Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Regions (2021-2025) (K Dose)
Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Regions (2021-2025)
Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2025) (K Dose)
Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2021-2025)
Table 59. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2025)
Table 60. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2021-2025)
Table 61. Direct Channel Pros & Cons
Table 62. Indirect Channel Pros & Cons
Table 63. Distributors/Traders/ Dealers List
List of Figures
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Picture
Figure 2. Global Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2019
Figure 3. Single Dose Vial Picture
Figure 4. Pre-filled Syringe Picture
Figure 5. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2019
Figure 6. For Children (2-10) Picture
Figure 7. For Person (10-64) Picture
Figure 8. For The Old (≥65) Picture
Figure 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2018
Figure 46. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 49. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 50. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 55. UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 56. France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 57. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 58. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 59. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions 2019
Figure 62. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 63. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 64. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 65. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 66. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 67. South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2019
Figure 69. South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 71. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 72. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 77. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 78. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 79. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2015-2020) (K Dose)
Figure 80. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2025) (K Dose)
Figure 81. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 83. Europe Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 84. Asia-Pacific Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 85. South America Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 86. Middle East & Africa Sales 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2021-2025) (K Dose)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
肺炎球菌ワクチンの世界市場 2020年 Market Overview The Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 水溶性大豆多糖類の世界市場 2020年 Market Overview The Soybean Soluble Polysaccharide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- ワクチンの世界市場 2020年 Market Overview The Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 結合型ワクチンの世界市場 2020年 Market Overview The global Conjugate Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 10930 million by 2025, from USD 9687.6 million in 2019. The Conjugate Vaccine m…
- 鼻インフルエンザワクチンの世界市場 2020年 Market Overview The Nasal Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…